Multiomics Market Value Is Anticipated To Reach $8.06 Billion By 2030, Driven By Key Growth Factors

 

How Significant Is The Future Market Potential Of The Multiomics Market Based On Its Projected Size And Growth Rate?
 The multiomics market size has grown rapidly in recent years. It will grow from $3.85 billion in 2025 to $4.52 billion in 2026 at a compound annual growth rate (CAGR) of 17.6%. The growth in the historic period can be attributed to rise in genomic sequencing adoption, early development of transcriptomics tools, increased availability of proteomic analysis platforms, expansion of biomarker identification research, growth in biological data generation.
 
 The multiomics market size is expected to see rapid growth in the next few years. It will grow to $8.07 billion in 2030 at a compound annual growth rate (CAGR) of 15.6%. The growth in the forecast period can be attributed to advancements in multiomics platforms, rising demand for personalized medicine, increased integration of ai-based analytics, growing use of metabolomics in clinical settings, expanding multiomics applications in precision agriculture. Major trends in the forecast period include growing adoption of single-cell multiomics, rising integration of multi-layer biological data, increased use of multiomics in early disease diagnostics, expansion of multiomics in drug discovery pipelines, growing application of multiomics in agricultural genomics.
 
 Claim Your Free Report Sample Today:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=15866&type=smp
 
 Which Major Drivers Are Strengthening Demand In The Multiomics Market?
 The rising demand for personalized medicine is expected to propel the growth of the multiomics market going forward. Personalized medicine refers to a medical approach that customizes healthcare decisions and treatments to individual patients based on their genetic, environmental, and lifestyle factors. This personalized medicine approach is rising due to technological advancements, increasing demand for targeted therapies, and global healthcare improvements. Multiomics helps personalized medicine by providing a detailed understanding of an individual’s genetic, molecular, and metabolic profile, enabling healthcare providers to tailor treatments based on the specific characteristics of each patient. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, compared to 6 in 2022. Therefore, the rising demand for personalized medicine is driving the growth of the multiomics market.
 
 How Is The Multiomics Market Divided Across Its Major Segment Categories?
 The multiomics market covered in this report is segmented — 
 
 1) By Type: Single-Cell Multiomics, Bulk Multiomics
 2) By Platform: Genomics, Transcriptomics, Proteomics, Metabolomics, Integrated Omics Platforms
 3) By Application: Diagnostics, Drug Discovery And Development, Personalized Medicine, AgriGenomics, Other Applications
 4) By End User: Academics And Research Organization, Pharmaceutical And Biotechnology Companies, Clinical research Organization, Other End-Users
 
 Subsegments:
 1) By Single-Cell Multiomics: Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Epigenomics, Single-Cell Proteomics, Single-Cell Metabolomics
 2) By Bulk Multiomics: Genomics, Transcriptomics, Epigenomics, Proteomics, Metabolomics
 
 Which Trends Are Currently Influencing The Direction Of The Multiomics Market?
 Major companies operating in the multiomics market are developing advanced single-cell multiomics platforms to enable scientists to run large-scale studies without sacrificing sample integrity. Single-cell multiomics platforms integrate various omics with artificial intelligence capabilities, allowing users to seamlessly analyze and interpret complex biological data through sophisticated algorithms and machine learning techniques. For instance, in February 2023, Becton, Dickinson, and Company, a US-based medical device company, launched the BD Rhapsody HT Xpress, a high-throughput single-cell multiomics platform. This innovative system enables scientists to isolate, barcode, and analyze single cells at a high sample throughput, accommodating up to eight times more cells than previous versions of BD single-cell analyzers. The BD Rhapsody HT Xpress System ensures no sample loss, offering flexibility to analyze multiple samples and different cell sizes and types simultaneously, such as stem cells or cancer cells, enhancing researchers’ ability to gain more insights in less time.
 
 Which Influential Players Dominate The Competitive Environment Of The Multiomics Market?
 Major companies operating in the multiomics market are Bayer AG, Thermo Fisher Scientific Inc., Novartis AG, Becton Dickinson and Company, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Shimadzu Corporation, Bruker Corporation, Bio-Techne, Azenta Life Sciences, 10x Genomics, Ginkgo Bioworks, Abcam limited, BioLegend, Oxford Nanopore Technologies Plc, Adaptive Biotechnologies, Pacific Biosciences, Standard BioTools, Parse Biosciences, Mission Bio, CD Genomics, Singleron Biotechnologies, Psomagen, BGI Group 
 
 Get Your In-Depth Multiomics Market Report Now:
 https://www.thebusinessresearchcompany.com/report/multiomics-global-market-report
 
 Which Regions Stand Out As Major Contributors To Future Demand In The Multiomics Market?
 North America was the largest region in the multiomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the multiomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
 
 Contact Us:
 
 The Business Research Company: https://thebusinessresearchcompany.com/ 
 Americas +1 310–496–7795
 Asia +44 7882 955267 & +91 8897263534
 Europe +44 7882 955267 
 Email: info@tbrc.info 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company